Bavarian's JYNNEOS has also been approved by the U.S. Food and Drug Administration (FDA) but only for adults 18 years and ...

Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. health ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Indian equity markets witnessed a remarkable surge, with both the Sensex and Nifty reaching new record highs. This upward momentum was largely attributed to a rally in global markets following the U.S ...

DEAR DR. ROACH: Could you please comment on keto and apple cider vinegar (ACV) gummies for weight loss? They are promoted by ...

Plus: The story behind the award-winning science that led to Ozempic, the next astronaut launch and why homework is good for ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

Will neurotechnologies gradually invade the world of work? The question is worth asking, given the progress made in this ...

Join Fox News for access to this content Plus special access to select articles and other premium content with your account - free of charge. By entering your email and pushing continue, you are ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...